PMV Pharmaceuticals Initiates Strategic Lease Termination
Company Announcements

PMV Pharmaceuticals Initiates Strategic Lease Termination

PMV Pharmaceuticals (PMVP) has issued an announcement.

PMV Pharmaceuticals, Inc. has negotiated an early termination of its lease for their Princeton, New Jersey property, effective September 30, 2024, subject to the property’s sale to a new buyer. The company will vacate the 50,581 square foot space and pay a termination fee of about $1.42 million, which includes both a cash payment and a security deposit. This strategic move is part of PMV’s cost-cutting initiatives, as they plan to move to a smaller, more cost-efficient headquarters and laboratory space.

Find detailed analytics on PMVP stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyPMV provides update on Phase 2, Phase 1b portions of PYNNACLE trial
TheFlyPMV Pharmaceuticals sees cash runway to end of 2026
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App